Crowley John F 4
4 · AMICUS THERAPEUTICS, INC. · Filed Jan 11, 2024
Insider Transaction Report
Form 4
Crowley John F
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-01-10$13.65/sh−31,614$431,452→ 869,393 total - Tax Payment
Common Stock
2024-01-09$13.65/sh−36,865$503,207→ 901,007 total
Holdings
- 64,895(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.48 to $13.96 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.